Lipoprotein Management in ACS: Improving Outcomes in Patients with Complex Lipid Disorders

Share:


Registration Statement


By clicking the Registration Button below you are agreeing that you have read and understood the CME Statements below.


Registration

  VenueCityStateDate
View Agenda  ACE Conference CenterLafayette HillPA Saturday
Oct 22, 2011 5:00 PM
View Agenda  Montelucia Resort & SpaScottsdaleAZ Saturday
Nov 19, 2011 7:00 AM
View Agenda  Grand Hyatt San FranciscoSan FranciscoCA Saturday
Dec 17, 2011 12:00 AM


This program has an associated Grand Rounds Click Here for information.

Venues

  Venue City State Date  
View Agenda  ACE Conference Center Lafayette Hill Pennsylvania Saturday, October 22, 2011  5:00 - 6:45 PM To register scroll down.
  Venue City State Date  
View Agenda  Montelucia Resort & Spa Scottsdale Arizona Saturday, November 19, 2011  7:00-8:30 AM To register scroll down.
  Venue City State Date  
View Agenda  Grand Hyatt San Francisco San Francisco California Saturday, December 17, 2011  12:00-1:00 PM To register scroll down.


Program Overview


Despite the use of sufficient statin therapy to achieve stringent low-density lipoprotein (LDL) goals, many dyslipidemic patients are at an unacceptably high risk for cardiovascular disease (CVD) events. This disturbingly high residual risk clearly illustrates the need for accessible education, so that clinicians who play a key role in the management of these patients can keep abreast of current and emerging strategies for the treatment of complex dyslipidemia, particularly conditions that are characterized by low high-density lipoprotein (HDL) levels.

 

Upon completion of this educational activity, participants will have a better understanding of the importance of HDL in protecting against adverse CV events, as well as the CVD risks associated with low HDL levels. They will learn critical information about the role of HDL and HDL-targeted therapies to help make informed decisions and optimize treatments to improve the clinical outcomes of dyslipidemic patients. The unique delivery format of this educational initiative combines high-level faculty and participant interactions with reinforcement of educational messages to promote lasting clinical insights on the potential clinical utility of raising HDL and to improve the quality of care of patients with CVD.


Target Audience


This program is intended for cardiologists and other professionals who manage high-risk dyslipidemic patients.

Educational Objectives


This program is designed to address the following IOM competencies: provide patient-centered care and employ evidence-based practice.

At the conclusion of this activity, participants should be able to demonstrate the ability to:

  • Examine the need for comprehensive lipid management in dyslipidemic patients who sustain an ACS
  • Compare the relative effectiveness of existing treatments to raise HDL and reduce CVD risk
  • Explain the rationale for developing novel agents to increase HDL
  • Provide an overview of clinical trials evaluating efficacy and safety of emerging therapies to modulate HDL

Accreditation


This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Potomac Center for Medical Education and Rockpointe. Potomac Center for Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement


The Potomac Center for Medical Education designates this educational activity for a maximum of 1.0 AMA PRA Category 1 credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

For questions regarding CME credit, the post-test, or evaluation, please email contact@potomacme.org.


Disclosure Information


The Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.

All persons in a position to control the content of a continuing medical education program sponsored by PCME are required to disclose any relevant financial relationships with any commercial interest to PCME as well as to learners. All conflicts are identified and resolved by PCME in accordance with the Standards for Commercial Support in advance of delivery of the activity to learners. Disclosures will be made known to the participants prior to the activity.

The content of this activity was vetted by an external medical reviewer to assure objectivity and that the activity is free of commercial bias.


METHOD OF PARTICIPATION


In order to successfully complete this activity, participant must attend the live meeting and complete the participant evaluation. Participants will receive a certificate of credit at the program from onsite logistical staff upon receipt of the evaluation.

There is no fee associated with this program.


SPECIAL SERVICES


Event staff will be glad to assist you with any special needs (e.g. physical, dietary, etc.). Please email specialservices@potomacme.org.


Jointly Sponsored By


      

Supported By


Supported by an educational grant from:



Registration Statement


By clicking the Registration Button below you are agreeing that you have read and understood the CME Statements above.



Registration

  VenueCityStateDate
View Agenda  ACE Conference CenterLafayette HillPA Saturday
Oct 22, 2011 5:00 PM
View Agenda  Montelucia Resort & SpaScottsdaleAZ Saturday
Nov 19, 2011 7:00 AM
View Agenda  Grand Hyatt San FranciscoSan FranciscoCA Saturday
Dec 17, 2011 12:00 AM